ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Hypothermic Machine Perfusion Improves Outcomes in DCD Kidneys

L. Szabo, P. Laftsidis, A. Asderakis, E. Ablorsu

Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom

Meeting: 2013 American Transplant Congress

Abstract number: C1269

Background

To overcome organ shortage, utilization of kidneys from DCD donors has increased. Those kidneys have comparable long-term outcomes as DBD kidneys, however they have higher incidence of DGF and worse initial graft function. Published data supports favourable impact of pulsatile Hypothermic Machine Perfusion (HMP) on DCD kidneys.

Aim of this study was to assess the effect of HMP on the early function of controlled DCD kidneys.

Methods

We analysed prospectively collected data of 130 consecutive controlled DCD kidney transplants performed in a single centre between 1 January 2010 and 22 October 2012. Subsequently we compared DCD kidneys preserved on HMP (N=52), using the LifePort© (from Organ Recovery Systems) to DCD kidneys stored in Cold Storage (CS) (N=78). We excluded DCD kidneys transplanted in combination with pancreas and those performed as double transplants.

Results

The mean donor age in HMP group was 59.09±1.83 years (mean±SD) and 56.26±11.14 years in CS group (p=0.28). There was no significant difference in recipient age 59.65±19.84 years in HMP group vs. 57.85±12.13 years in CS (p= 0.40); however Cold Ischaemia Time (CIT) was significantly longer in HMP group (14.73±4.3 hours) compared to CS group (11.32±4.5 hours), p<0.001. We found no difference in the incidence of functional DGF, 65.4% and 74.4% in HMP and CS groups repectively (p=0.27). Also, the eGFRs were similar at any time point.

In a logistic regression analysis, we found that higher donor age (Exp(B)=1.029, p=0.038), longer CIT (Exp(B)=1.114, p=0.031) and CS as the type of storage (Exp(B)=2.5, p=0.043), were significantly increasing the risk of DGF.

In linear regression analysis the donor age, CIT, and type of storage showed significant correlation with the eGFR at 1, 3 and 6 months. At 1 and 2 years only the donor age correlated significantly with the eGFR.

Summary

HMP, in DCD kidneys with long CIT, can neutralise the adverse effect of cold preservation, leading to at least equivalent early graft function and similar incidence of DGF compared to kidneys preserved by static CS for significantly shorter preservation time.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Szabo L, Laftsidis P, Asderakis A, Ablorsu E. Hypothermic Machine Perfusion Improves Outcomes in DCD Kidneys [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/hypothermic-machine-perfusion-improves-outcomes-in-dcd-kidneys/. Accessed May 14, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences